STOKStoke Therapeutics, Inc.
$24.71+7.9% 1Y
$24.71
$22.3752 weeks$38.35
Is the price fair?
What STOK's price assumes
Stoke Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 10.3× revenue.
10.3
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 5.37
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 8.72
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 5.37
- EV / EBIToperating margin −810%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 8.72
- Market capitalisation
- $1.89B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks